MedPath

Bone Morphogenetic Protein-2 In Grade II Furcation Defects.

Not Applicable
Completed
Conditions
Periodontitis
Interventions
Procedure: PLATELET RICH FIBRIN in grade II furcation
Registration Number
NCT04372420
Lead Sponsor
SVS Institute of Dental Sciences
Brief Summary

The present study evaluated clinically and radiographically the regenerative potential of rhBMP-2 in absorbable sponge and PRF in Grade II furcation.

Detailed Description

44 subjects were enrolled in the study. PPD, CAL, plaque index and gingival index were recorded and the evaluation of bone fill was performed after 6 months by using ImageJ® software. After 6 months, the bone fill obtained with rhBMP-2 was higher when compared to PRF. From this trial conducted over a period of 6 months, the unique properties associated with rhBMP-2 in absorbable sponge makes it a potential agent to be used as a graft material for Grade II furcation defects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Systemically healthy male and female patients of age group 20-55 yrs
  • grade II furcation involvement and probing pocket depth of ≥5mm
Exclusion Criteria
  • Medically compromised patients
  • subjects who underwent radiotherapy or chemotherapy in the past 12 months
  • patients having uncontrolled periodontal disease and
  • subjects smoking ≥10 cigarettes per day were excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RhBMP-2RhBMP-2 absorbable sponge in grade II furcationRhBMP-2 belongs to TGF-β super family with osteoinductive property which is capable of promoting bone formation
PLATELET RICH FIBRINPLATELET RICH FIBRIN in grade II furcationPlatelet rich fibrin(PRF) is a healing biomaterial with a great potential for bone and soft tissue regeneration, without any inflammatory reactions
Primary Outcome Measures
NameTimeMethod
BONE FILL6 MONTHS

The evaluation of bone fill was performed after 6 months by using ImageJ® software.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

RV Chandra

🇮🇳

Hyderabad, Telangana, India

© Copyright 2025. All Rights Reserved by MedPath